Clinical Trial Update: Docetaxel and Gemcitabine in Hormonal Refractory Metastatic Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

This document summarizes a completed Phase 1/2 clinical trial evaluating the combination of docetaxel and gemcitabine in hormonally refractory metastatic prosta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Herlev Hospital | Conditions: Prostate Cancer | Phase 1, Phase 2 | Status: COMPLETED